Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme
|針對症狀||Brain and Central Nervous System Tumors|
|臨床試驗位址||Hoag Cancer Institute at Hoag Memorial Hospital Presbyterian|
|目前研究進度||This study has been completed.|
|試驗開始日期||May 30, 2006|
|試驗開始日期||October 1, 2011|
RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, may stimulate the immune system in different ways and stop tumor cells from growing. Aldesleukin may stimulate the white blood cells, including lymphokine-activated killer cells, to kill tumor cells. Giving cellular adoptive immunotherapy during or after surgery may kill more tumor cells.
PURPOSE: This phase II trial is studying how well cellular adoptive immunotherapy works in treating patients with glioblastoma multiforme.